Cancer in the omentum is overwhelmingly metastatic rather than primary, meaning it almost always starts somewhere else and spreads to the omentum secondarily. Ovarian cancer is the most common source, but cancers of the stomach, colon, and appendix also frequently seed this tissue. True primary omental cancers exist but are exceptionally rare, with fewer than 50 reported cases across all tumor types. The distinction matters because the origin of the cancer dictates how it is staged, treated, and what a patient can expect going forward.
What the Omentum Is and Why It Matters
The omentum is a large, apron-like fold of fatty tissue that drapes over the intestines inside the abdomen. Most people have never heard of it, but it plays a surprisingly active role in immune defense. Far from being inert padding, the omentum contains specialized immune clusters called milky spots, which are collections of macrophages and lymphocytes that filter the fluid inside the abdominal cavity, trapping pathogens and debris.1PubMed Central. The Greater Omentum-A Vibrant and Enigmatic Immunologic Organ Involved in Injury and Infection Resolution It also has a remarkable ability to physically migrate toward sites of injury or infection, essentially wrapping itself around a problem area to contain it. Surgeons have long observed the omentum adhering to inflamed appendixes or perforated ulcers, acting as a biological patch.
The omentum’s immune and metabolic activity, however, creates a paradox. The same features that make it good at detecting threats also make it hospitable to cancer cells. Its milky spots actively collect particles and cells from the abdominal cavity, and its rich fat stores provide energy. For a cancer cell floating free in the peritoneal fluid, the omentum is both a landing pad and a fuel station.2PubMed Central. Immunological Functions of the Omentum
Why Cancer Homes In on the Omentum
When cancers spread within the abdominal cavity, they do not scatter randomly. They preferentially colonize the omentum, and researchers have worked out a two-step model for why. In the first step, cancer cells drifting through peritoneal fluid are captured by milky spots, the same immune clusters that normally trap bacteria and antigens. These milky spots sit near small blood vessels and pull in circulating material from the surrounding fluid. Cancer cells exploit this filtering mechanism to anchor themselves.3PubMed Central. Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models
In the second step, the omentum’s abundant fat cells fuel the cancer’s growth. Adipocytes release fatty acids that tumor cells can use as an energy source for rapid proliferation. Laboratory studies show that as the tumor burden in the omentum increases, the fat content of the omentum decreases, consistent with the idea that cancer cells are literally consuming the tissue’s fat reserves.4PubMed Central. Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis This makes the omentum one of the first and most common sites of peritoneal metastasis, and it is routinely removed during staging and treatment of abdominal cancers for exactly this reason.
The Cancers That Most Commonly Involve the Omentum
Ovarian cancer is the single most common malignancy to spread to the omentum. In advanced-stage ovarian cancer, the omentum is affected so frequently that total omentectomy is considered a standard part of debulking surgery, even when the tissue appears normal to the naked eye.5PubMed. Is routine omentectomy of grossly normal omentum helpful in surgery for ovarian cancer? A look at the tumor microenvironment and its clinical implications Gastric cancer, colorectal cancer, and appendiceal cancer also frequently metastasize to the omentum, particularly when they produce what is called peritoneal carcinomatosis, a condition where cancer cells seed the lining of the abdominal cavity. In these cases the omentum often develops a characteristic thickening visible on imaging, sometimes called an “omental cake.”
The term “omental cake” sounds oddly casual, but it describes a well-recognized radiologic finding: a solid, matted mass where the normally soft, fatty omentum has been replaced or infiltrated by tumor. Although omental caking is most associated with ovarian cancer, it can also be caused by gastric cancer, lymphoma, and even some non-cancerous conditions like tuberculosis or sclerosing omentitis.6PubMed Central. Omental cakes: unusual aetiologies and CT appearances This overlap means that imaging alone cannot confirm cancer, and biopsy is usually needed.
Primary Omental Tumors
Primary cancers that originate in the omentum itself, rather than spreading there from elsewhere, are genuinely rare. Fewer than 50 cases of primary malignant tumors of the greater omentum have been reported in the medical literature.7PubMed Central. Primary Omentum Malignant Hemangiopericytoma Present with Acute Abdomen The types that do arise include mesothelioma, gastrointestinal stromal tumors (GISTs), leiomyosarcomas, and hemangiopericytomas. Each behaves differently.
Omental GISTs, for example, are a subset of extragastrointestinal stromal tumors, meaning they share the molecular features of GISTs found in the stomach or intestine but grow in the omentum without any connection to the gut wall.8PubMed. Primary omental gastrointestinal stromal tumors A large analysis of 95 omental GISTs found that they are a mixed group: patients with a single tumor tend to have a better outlook, with a median survival of about 11 years, while those with multiple omental tumors face much worse outcomes, with a median survival of only 8 months.9The American Journal of Surgical Pathology. Gastrointestinal Stromal Tumors Presenting as Omental Masses—A Clinicopathologic Analysis of 95 Cases Primary omental mesothelioma has also been reported in patients with no history of asbestos exposure, though this is exceedingly unusual.10PubMed. Primary malignant mesothelioma of the greater omentum: report of a case
Symptoms
Omental cancer, whether primary or metastatic, tends to be clinically silent in its early stages. The omentum is a spacious, compliant tissue, so a growing mass can reach a considerable size before it presses on nearby structures enough to cause noticeable symptoms. When symptoms do appear, they are frustratingly nonspecific.
A review of reported primary omental tumor cases found that the most common complaints were abdominal discomfort, occurring in about 56% of cases, and a palpable abdominal mass, in about 35%. Weight loss, ascites (fluid buildup in the abdomen), and the presence of peritoneal implants were warning signs that the tumor was malignant rather than benign.11PubMed. Primary solid neoplasms of the greater omentum Other reported symptoms include early satiety, meaning feeling full after eating very little, and in some cases lower back pain from a mass pressing on posterior structures.
For metastatic omental disease, the symptom picture is often dominated by ascites. Tumor deposits on the omentum can increase the permeability of blood vessels in the tissue, causing protein-rich fluid to leak into the abdominal cavity. This mechanism explains why some patients develop large-volume ascites even before tumor deposits are large enough to physically block lymphatic drainage.12PubMed Central. Malignant ascites. Clinical and experimental observations The resulting abdominal swelling, bloating, and shortness of breath from upward pressure on the diaphragm are often what bring patients to medical attention.
Diagnosis
Omental disease is usually discovered on cross-sectional imaging, typically a CT scan of the abdomen. The classic finding in metastatic disease is the omental cake described earlier. In earlier or more subtle cases, imaging may show scattered nodular thickening or small deposits within the omental fat. However, not every omental abnormality is cancer. Benign conditions like extramedullary hematopoiesis (seen in patients with bone marrow disorders like myelofibrosis), amyloidosis, and sclerosing omentitis can all create thickened or calcified omental masses that look worryingly similar to malignancy on CT.6PubMed Central. Omental cakes: unusual aetiologies and CT appearances
Because of this overlap, tissue sampling is critical. CT-guided core needle biopsy of omental lesions performs well, with one study reporting a sensitivity of about 90% and specificity of 100% for detecting malignancy, and the ability to identify the specific type of cancer in roughly 79% of malignant cases.13PubMed Central. Omental cakes: unusual aetiologies and CT appearances – Section: Role of image-guided biopsy Knowing the exact cancer type guides the entire treatment plan, since metastatic ovarian cancer, a primary omental GIST, and peritoneal mesothelioma all require completely different approaches.
For staging, clinicians use the peritoneal cancer index, a scoring system that divides the abdominal cavity into regions and rates each one by the size of the largest tumor deposit. In gastric cancer with peritoneal spread, a score of 6 or below has emerged as a threshold for what is considered “oligometastatic” disease, meaning limited enough that aggressive treatment can aim for long-term survival.14PubMed Central. Peritoneal Oligometastasis in Gastric Cancer: Diagnostic Strategies, Patient Selection, and Emerging Therapeutic Approaches
Surgical Treatment and Omentectomy
Surgery is the cornerstone of treatment when omental cancer is resectable. In most situations, this means removing the omentum entirely, a procedure called omentectomy, as part of a broader debulking or cytoreductive operation. For ovarian cancer specifically, the question of how much omentum to remove has practical implications. A randomized trial comparing infragastric omentectomy (removing the omentum from below the stomach) to infracolic omentectomy (a more limited removal from below the transverse colon) found that the more extensive approach was about six and a half times better at detecting hidden omental metastases and improved progression-free survival in patients with disease beyond stage IIB, without increasing surgical complications.15PubMed Central. A randomized controlled trial to compare short-term outcomes following infragastric and infracolic omentectomy at the time of primary debulking surgery for epithelial ovarian cancer with normal-appearing omentum
Even when the omentum looks completely normal during surgery, there is a strong argument for removing it. In patients undergoing cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC) for various abdominal cancers, about one-third of those whose omentum appeared grossly normal were found to have microscopic metastases on pathologic examination. Among patients whose omentum was left in place, roughly one-fifth went on to develop omental recurrence.16PubMed Central. Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC? These findings have led many oncologic surgeons to treat omentectomy as a standard component of abdominal cancer surgery, not an optional add-on.
Living Without an Omentum
A natural question after learning that the omentum is routinely removed is whether you can function normally without it. In general, yes. A systematic review of the short- and long-term consequences of omentectomy found that complication rates were low overall. Short-term issues like bowel obstruction, abdominal abscess, and sepsis occurred in up to 23% of patients in some series, though rates were often much lower. The most commonly reported long-term complication was a hernia at the surgical site, occurring in up to 32% of patients in some reports. Gastrointestinal problems after the procedure were minimal.17PubMed. What are the short- and long-term abdominal consequences of an omentectomy? A systematic review The omentum’s immune and wound-healing roles are real, but other parts of the immune system compensate sufficiently in most patients.
Cytoreductive Surgery and HIPEC
For patients with peritoneal carcinomatosis involving the omentum, the gold-standard aggressive approach combines cytoreductive surgery with HIPEC. During cytoreduction, the surgeon removes all visible tumor from the abdominal cavity, including the omentum, affected peritoneum, and any other involved organs. Immediately after, heated chemotherapy is circulated directly through the abdomen. The heat improves drug penetration into residual tumor cells, and delivering the drugs locally means higher concentrations reach the tissue than would be possible with intravenous chemotherapy alone.
This combined approach has shown encouraging results across several cancer types. For ovarian cancer with diffuse peritoneal spread, studies report promising long-term survival with acceptable rates of complications and mortality.18PubMed. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer For appendiceal cancer with peritoneal spread, CRS-HIPEC with oxaliplatin has similarly demonstrated encouraging long-term overall survival.19PubMed. Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis Patient selection is critical; the best outcomes are seen when surgeons can remove all visible disease, and the peritoneal cancer index helps identify who is most likely to benefit.
Prognosis and What Drives It
The prognosis for omental cancer depends heavily on whether the disease is primary or metastatic, which cancer is involved, and how much tumor remains after surgery. For advanced ovarian cancer, the presence or absence of omental metastasis is itself a major prognostic marker. One study of stage III-IV epithelial ovarian cancer found that patients with omental metastases had a five-year overall survival of about 43%, compared to roughly 94% for those without omental involvement. In multivariate analysis, omental metastasis was an independent risk factor for death, with a hazard ratio near 9.20PubMed Central. Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer
In type 2 endometrial cancer, a similarly aggressive pattern emerged. Patients whose omentum contained gross tumor deposits had a five-year overall survival of only about 27%, compared to roughly 64% for patients whose omentum was free of disease. Those with occult metastases, meaning disease visible only under the microscope, fell in between at about 53%.21PubMed. Risk factors for omental metastasis and the effect of omentectomy on survival in type 2 endometrial cancer patients These numbers underscore that omental involvement is not just a staging detail; it is a meaningful signal about how aggressively the cancer is behaving.
Emerging Approaches
For patients who are not candidates for full cytoreductive surgery, or whose disease recurs after initial treatment, newer locoregional therapies are being investigated. One of the more novel developments is pressurized intraperitoneal aerosol chemotherapy, or PIPAC. This technique delivers chemotherapy as a fine aerosol spray during a minimally invasive laparoscopy. The pressurized environment created during the procedure may improve how deeply the drug penetrates into tumor tissue compared to conventional intraperitoneal delivery.22PubMed. Intraperitoneal aerosolized drug delivery: Technology, recent developments, and future outlook PIPAC is less invasive than open CRS-HIPEC and can be repeated multiple times, making it an option for palliative treatment or as a bridge in patients who might become surgical candidates after tumor regression.
Symptom management remains a major part of care for patients with advanced omental disease, particularly the management of recurrent ascites and bowel obstruction. Repeated drainage of ascitic fluid, placement of indwelling abdominal catheters, and medications that reduce fluid production can all help maintain quality of life. For malignant bowel obstruction, a combination of medications to control nausea and reduce secretions, sometimes combined with venting gastrostomy tubes or surgical bypasses, allows many patients to stay at home and maintain independence.23International Journal of Cancer and Clinical Research. Palliative Management of Malignant Bowel Obstruction with Carcinomatosis These palliative strategies are not consolation prizes; for patients with unresectable disease, they are often the interventions that most directly affect day-to-day comfort and function.
Conditions That Mimic Omental Cancer
Not every abnormal-looking omentum on a CT scan turns out to be cancer, and this is worth knowing because the anxiety of seeing an omental mass on imaging can be intense. Tuberculosis of the peritoneum can produce omental thickening and caking that looks remarkably similar to carcinomatosis on imaging. Sclerosing omentitis, a chronic inflammatory condition of unknown cause, creates firm, calcified omental masses that can be mistaken for ovarian cancer or mesothelioma.6PubMed Central. Omental cakes: unusual aetiologies and CT appearances Amyloidosis, a condition where abnormal proteins deposit in tissues, can similarly infiltrate the omentum. And in patients with bone marrow disorders like myelofibrosis, the omentum can become a site of extramedullary hematopoiesis, essentially acting as backup blood-cell production space, creating masses that are completely benign but alarming on a scan.
These mimics are another reason tissue biopsy is so important before assuming a diagnosis. They also explain why an experienced radiologist’s read is valuable: the pattern of calcification, the distribution of thickening, and the presence or absence of ascites can all provide clues, even before a needle touches the tissue. For patients awaiting biopsy results after an omental abnormality is found, it is reasonable to ask about these non-cancerous possibilities. They are uncommon, but they exist, and not every omental cake is a death sentence.